AnandRathi

Parmax Pharma Ltd Fundamental Analysis

Last Updated Date: 15 Sept 2026
135.05
+1.30 (+0.97%)

Parmax Pharma Ltd (Parmax Pharma) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹93 crore.

Parmax Pharma Ltd Overview

Market cap₹93 Crs
Volume6,334
Prev. Close₹133.75
Year range₹22.60 - ₹135.05
ISININE240T01014

Parmax Pharma Ltd Fundamentals

ROCE(TTM)-85.76%
P/E Ratio (TTM)-77.61
P/B Ratio20.22
Debt to Equity-1.87
ROE67.65%
EPS (TTM)0.00
Dividend Yield0.00%
Book Value6.68
Profit Margin-6.47%
Operating Margin-20.45%

Parmax Pharma Ltd Historical Performance

1 Month Return14.69%
6 Month Return408.85%
3 Year Return345.71%
3 Month Return116.84%
1 Year Return306.53%
5 Year Return230.20%

Parmax Pharma Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research